Jan 30 (Reuters) - Dova Pharmaceuticals Inc:
* DOVA PHARMACEUTICALS ANNOUNCES THE APPOINTMENT OF MARK W. HAHN AS CHIEF FINANCIAL OFFICER
* DOVA PHARMACEUTICALS INC - ‍DOUG BLANKENSHIP, DOVA‘S PREVIOUS CHIEF FINANCIAL OFFICER, HAS AGREED TO STEP DOWN​
* DOVA PHARMACEUTICALS INC - MARK WILL OFFICIALLY COMMENCE IN HIS ROLE AS CHIEF FINANCIAL OFFICER OF DOVA ON JANUARY 31, 2018 Source text for Eikon: Further company coverage:
 